About Self-screen
Self-screen is a company based in Amsterdam (Netherlands) founded in 2008.. Self-screen offers products and services including HPV-Risk Assay, PreCursor-M+/QIAsure Methylation Test, PreCursor-M AnoGYN, and PreCursor-M Gold Methylated DNA. Self-screen operates in a competitive market with competitors including Aindra, Teal Health, Femasys, MTM Laboratories and OncoHealth, among others.
- Headquarter Amsterdam, Netherlands
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Self-Screen B.V.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$336.57 K (USD), Grant
Jan 01, 2020
-
Investors
European Union
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Self-screen
Self-screen offers a comprehensive portfolio of products and services, including HPV-Risk Assay, PreCursor-M+/QIAsure Methylation Test, PreCursor-M AnoGYN, and PreCursor-M Gold Methylated DNA. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Detects HPV infections for cervical cancer risk assessment.
Identifies progressing premalignant lesions in HPV-positive women.
Screens for cervical cancer precursors using molecular markers.
Analyzes methylated DNA for early cancer detection purposes.
Unlock access to complete
Funding Insights of Self-screen
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $336,565
-
First Round
First Round
(01 Jul 2015)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2020 | Amount | Grant - Self-screen | Valuation |
investors |
|
| Mar, 2019 | Amount | Grant - Self-screen | Valuation |
investors |
|
| Jul, 2015 | Amount | Grant - Self-screen | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Self-screen
Self-screen has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Self-screen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Self-screen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Self-Screen Comparisons
Competitors of Self-screen
Self-screen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aindra, Teal Health, Femasys, MTM Laboratories and OncoHealth, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-powered systems for cervical cancer detection are provided.
|
|
| domain | founded_year | HQ Location |
Cervical cancer screening kits are provided by Teal Health.
|
|
| domain | founded_year | HQ Location |
Medical devices for women's healthcare are developed and provided.
|
|
| domain | founded_year | HQ Location |
In vitro diagnostics for early cervical cancer detection are manufactured.
|
|
| domain | founded_year | HQ Location |
OncoHealth is focused on delivering oncology-focused digital health solutions.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Self-Screen
Frequently Asked Questions about Self-screen
When was Self-screen founded?
Self-screen was founded in 2008 and raised its 1st funding round 7 years after it was founded.
Where is Self-screen located?
Self-screen is headquartered in Amsterdam, Netherlands.
What does Self-screen do?
Self-screen was established in 2008 in Amsterdam, Netherlands, within the healthcare diagnostics sector. Molecular assays for the early detection of anogenital cancers are developed and implemented clinically by the company. Self-screening tools, including the HPV-Risk Assay, PreCursor-M, and QIAsure Methylation Test, are provided to support cervical cancer screening efforts across relevant geographies. Operations emphasize practical application in medical settings.
Who are the top competitors of Self-screen?
Self-screen's top competitors include Femasys, OncoHealth and Aindra.
What products or services does Self-screen offer?
Self-screen offers HPV-Risk Assay, PreCursor-M+/QIAsure Methylation Test, PreCursor-M AnoGYN, and PreCursor-M Gold Methylated DNA.
Who are Self-screen's investors?
Self-screen has 2 investors. Key investors include European Union, and EIC Fund.